Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)

NCT06030544 is registered in ClinicalTrials.gov with Spanish National Research Council as lead sponsor.

NCT NCT06030544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06030544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)
Lead sponsor
Spanish National Research Council
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 25, 2022
Completion date
June 30, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic patients, type ii diabetes mellitus